0
2021
Endoscopic Retrograde Cholangiopancreatography Market

Endoscopic Retrograde Cholangiopancreatography Market

by Product Type (Endoscopes, Endotherapy Devices, Imaging Systems, Energy Devices, And Others), Application (Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, And Pancreatic Duct Stenting), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, And Others): Global Opportunity Analysis and Industry Forecast, 2019-2027
Update Available On-Demand

Report Code: A03846
Pages: 265
Apr 2021 | 6081 Views
Author(s) : Surabhi Pandey, Trupti Wadekar , Onkar Sumant
Tables: 122
Charts: 53
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Endoscopic Retrograde Cholangiopancreatography Market

Request Now !

The global endoscopic retrograde cholangiopancreatography market size was valued at $1,212.94 million in 2019, and is projected to reach $1,876.75 million by 2027, registering a CAGR of 5.6% from 2019 to 2027.

Endoscopy is a clinical process to observe body tissue or internal organs in detail or to conduct some minor surgery. Endoscopic retrograde cholangiopancreatography (ERCP) devices are medical equipment designed for pancreas to biliary system related disorders. These devices are gaining increased importance and adoption due to surge in prevalence of various bile ducts, and pancreatic and liver disorders such as Barrett's Disease., Biliary Disease, Colitis, Crohn's Disease, Gastroesophageal Reflux Disorder (GERD), liver Disease, Pancreatitis, Inflammatory Bowel Disease, Crohn’s Disease, Peptic Ulcer Disease. 

Endoscopic-Retrograde-Cholangiopancreatography-Market,-2019-2027

The COVID-19 pandemic has had a major global impact on endoscopic services. Furthermore, the infection is transmitted through contact and droplets. Therefore, healthcare providers of endoscopy are facing tremendous risk during the pandemic as the spread is mainly through direct contact or aerosol droplets, and endoscopy procedures require a short physical distance between patients and personnel. A report from Hong Kong, based on experience with SARS, showed that the risk of infection is 5% for physicians, 4% for nurses, and 8% for healthcare assistants. It emphasized the importance of practicing strict isolation, infection control measures, and adherence to use of personal protective equipment (PPE). Hence, the endoscopic retrograde cholangiopancreatography market is negatively impacted by the COVID-19 pandemic.

The growth of the global endoscopic retrograde cholangiopancreatography (ERCP) market is majorly driven by rise in incidences of gastrointestinal and chronic biliary disorders such as Barrett's disease, biliary disease, colitis, Crohn's disease, gastroesophageal reflux disorder (GERD), liver Disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. Further, rapid increasing frequencies of benign tumors of the liver and pancreas coupled with an increase in ageing population and surge in awareness related to devices used in ERCP for treatment of disorders. However, high costs associated with treatment from ERCP and side-effects of the procedure such as post-ERCP pancreatitis are expected to hamper the growth of the endoscopic retrograde cholangiopancreatography market. On the contrary, emerging countries possess high growth potential, owing to improvement of healthcare infrastructures in these countries. 

By product type, the endoscopic retrograde cholangiopancreatography (ERCP) market segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Further, endotherapy devices is divided into sphincterotome, lithotripter, stents, cannulas, forceps, snares, catheters, guiding wires, balloons, baskets, and others. By application, it is divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. By end user, it is segregated into hospitals & clinics, ambulatory surgery centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America endoscopic retrograde cholangiopancreatography market accounted for the largest share in 2019 followed by Europe; however, the Asia-Pacific region is anticipated to grow with the highest CAGR during the forecast period. 

Product Type segment review

By product type, the endotherapy devices segment held the largest share in 2019 and is anticipated to maintain its dominance during the forecast period, owing to increase in demand for ERCP therapeutics procedures, and rise in prevalence of choledocholithiasis, gallbladder stones, pancreatitis, and other bile duct & pancreatic duct diseases. Further, by endotherapy devices, the stents and sphincterotome segments held the largest share in 2019 and is estimated to grow at a CAGR of 3.7% and 3.8% respectively during the forecast period.

Endoscopic Retrograde Cholangiopancreatography Market
By Product Type

Your browser does not support the canvas element.

Endotherapy Devices segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the pancreatic sphincterotomy segment is expected to register highest CAGR during the forecast period, owing to increase in prevalence of population suffering from obstructing ductal calculi, ductal disruption & leak, sphincter stenosis, and dominant stricture of pancreas. Moreover, rise in demand for endoscopic technique which is used for various pancreas and pancreas-related diseases further fuels the growth of the endoscopic retrograde cholangiopancreatography market.

Endoscopic Retrograde Cholangiopancreatography Market
By Application

Your browser does not support the canvas element.

Surface Markers Separation Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region segment review

By region, North America accounted for the largest share in 2019, and is anticipated to maintain its dominance from 2019 to 2027, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure.

Endoscopic Retrograde Cholangiopancreatography Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 7.0% during 2019-2027.

Get more information on this report : Request Sample Pages

Some of the key players operating in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global endoscopic retrograde cholangiopancreatography market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The endoscopic retrograde cholangiopancreatography market forecast is studied from 2019 to 2027.
  • The endoscopic retrograde cholangiopancreatography market size and estimations are based on a comprehensive analysis of key developments in the endoscopic retrograde cholangiopancreatography industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the endoscopic retrograde cholangiopancreatography market.

Key Market Segments

By Product Type 

  • Endoscopes
  • Endotherapy Devices
    • Sphincterotome
    • Lithotripter
    • Stents
    • Cannulas
    • Forceps
    • Snares
    • Catheters
    • Guiding Wires
    • Balloons
    • Baskets
    • Others
  • Imaging Devices
  • Energy Devices
  • Others 

By Application 

  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting

By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

By Region 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • South Africa
    • Saudi Arabia 
    • Rest of LAMEA
 

Loading Table Of Content...


 
 

In accordance to several interviews conducted, the endoscopic retrograde cholangiopancreatography market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of choledocholithiasis, gallbladder stones, pancreatitis, and other bile duct & pancreatic duct diseases globally. The endoscopic retrograde cholangiopancreatography market is dominated by well-established players; hence, the market is anticipated to witness intense competition. The adoption of these devices has increased considerably, owing to adoption of technological advanced medical devices in the ERCP procedures, increase in gastrointestinal disorders, and rise in geriatric population, which propels the market growth. In addition, increase in product approval is expected to boost the market growth in the near future.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The major factor that fuels the growth of the Endoscopic Retrograde Cholangiopancreatography Market includes Increase in number of patients suffering from chronic disease and technological advancements in endosocpe and endotherpay devices primarily drive the growth of the Endoscopic Retrograde Cholangiopancreatography market. Similarly, surge in focus on personalized medicines for early detection of disease, selection of appropriate treatment, and determination of prognosis of the therapy are further expected to boost the market growth.

A. Yes, Endoscopic Retrograde Cholangiopancreatography companies are profiled in the report.

A. Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Cook Medical, and Conmed Corporation held a high market position in 2019.

A. Endotherapy Devices and endoscopes segment is the most influencing segment, owing to to increase in investments by the major players in the development of technologically advanced products as well as rising prevelance of diseases related to bile and pancreatic duct which fuels the growth of this segment.

A. The total market value of Endoscopic Retrograde Cholangiopancreatography Market is $1,213 million in 2019.

A. The forcast period for Endoscopic Retrograde Cholangiopancreatography Market is 2020 to 2027

A. The market value of Endoscopic Retrograde Cholangiopancreatography Market in 2020 is $1,139 million.

A. The base year is 2019 in Endoscopic Retrograde Cholangiopancreatography Market

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Endoscopic Retrograde Cholangiopancreatography Market

Start reading instantly.
This Report and over 18,878+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Apr 2022 - Apr 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2022 - Apr 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2022 - Apr 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2022 - Apr 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2022 - Apr 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers